EPYGENIX
Dead / Cancelled — Cancelled — Section 8 (as of 29 Nov 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87280153
- Registration number
- 5470599
- Mark type
- Design + words
- Filed
- 23 Dec 2016
- Published for opposition
- 12 Sept 2017
- Registered
- 15 May 2018
- Attorney of record
- Hunjoon Kim
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical, medical and scientific research and development in the field of pediatric genetic epilepsies excluding fields of nutrition and nutrition-related diseases
Owner
- Epygenix Therapeutics, Inc., Paramus, NJ, US
- Epygenix Therapeutics, Inc., Paramus, NJ, US
- Epygenix Therapeutics, Inc., Paramus, NJ, US
Prosecution history
- 29 Nov 2024 — CANCELLED SEC. 8 (6-YR)
- 15 May 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Dec 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Dec 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 May 2018 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Apr 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Mar 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Feb 2018 — USE AMENDMENT FILED
- 08 Mar 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Feb 2018 — TEAS STATEMENT OF USE RECEIVED
- 07 Nov 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Sept 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Sept 2017 — PUBLISHED FOR OPPOSITION
- 23 Aug 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED